Vios Medical Selected to Participate in Texas Medical Center’s TMCx Accelerator Program
Vios Medical, Inc., a medical technology company that develops patient-monitoring sensors and software, was selected to join other leading digital health startups as part of the Texas Medical Center’s TMCx accelerator. The program is designed to advance the development of innovative health care companies by connecting entrepreneurs to the clinical resources within the Texas Medical Center’s 59 member institutions. Participating companies also have access to more than 180 industry advisors offering health care industry expertise across multiple disciplines, including patient care, clinical operations, executive leadership, and fundraising.
“As we extend our capabilities in the medical technology industry, the relationships formed from the TMCx program are the building blocks that will support our continued realization of the economical and clinical value our technology brings to the market,” said Varun Verma, Senior Manager at Vios Medical.
The Vios Monitoring System is designed to optimize the management of patients through the continuum of care, providing a user-friendly, lower-cost and more efficient patient monitoring and care coordination platform than existing options. Utilizing sensors, unique signal processing IP, and proprietary software that runs on standard off-the-shelf hardware Vios medical can track patient vital signs on a variety of standard mobile devices, tablets, and computers. Healthcare providers will be able to monitor patient data in near real-time from any location without the enormous dependence on expensive hospital IT infrastructure.
The first generation Vios Monitoring System has FDA 510(k) clearance and is used commercially in hospitals overseas. The second-generation system is currently pending FDA clearance and is being piloted in multiple hospitals across the US and India.